These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Defective mesenchymal Bmpr1a-mediated BMP signaling causes congenital pulmonary cysts. Luo Y; Cao K; Chiu J; Chen H; Wang HJ; Thornton ME; Grubbs BH; Kolb M; Parmacek MS; Mishina Y; Shi W Elife; 2024 Jun; 12():. PubMed ID: 38856718 [TBL] [Abstract][Full Text] [Related]
3. C-reactive protein promotes acute kidney injury via Smad3-dependent inhibition of CDK2/cyclin E. Lai W; Tang Y; Huang XR; Ming-Kuen Tang P; Xu A; Szalai AJ; Lou TQ; Lan HY Kidney Int; 2016 Sep; 90(3):610-26. PubMed ID: 27470679 [TBL] [Abstract][Full Text] [Related]
4. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP). Fiori JL; Billings PC; de la Peña LS; Kaplan FS; Shore EM J Bone Miner Res; 2006 Jun; 21(6):902-9. PubMed ID: 16753021 [TBL] [Abstract][Full Text] [Related]
5. Negative Regulation of TGFβ Signaling by Stem Cell Antigen-1 Protects against Ischemic Acute Kidney Injury. Camarata TD; Weaver GC; Vasilyev A; Arnaout MA PLoS One; 2015; 10(6):e0129561. PubMed ID: 26053644 [TBL] [Abstract][Full Text] [Related]
6. Tubular transcriptional co-activator with PDZ-binding motif protects against ischemic acute kidney injury. Wu CL; Chang CC; Yang TH; Tsai AC; Wang JL; Chang CH; Tarng DC Clin Sci (Lond); 2020 Jul; 134(13):1593-1612. PubMed ID: 32558891 [TBL] [Abstract][Full Text] [Related]
7. Caspase-3 Is a Pivotal Regulator of Microvascular Rarefaction and Renal Fibrosis after Ischemia-Reperfusion Injury. Yang B; Lan S; Dieudé M; Sabo-Vatasescu JP; Karakeussian-Rimbaud A; Turgeon J; Qi S; Gunaratnam L; Patey N; Hébert MJ J Am Soc Nephrol; 2018 Jul; 29(7):1900-1916. PubMed ID: 29925521 [No Abstract] [Full Text] [Related]
8. Activation of ERK accelerates repair of renal tubular epithelial cells, whereas it inhibits progression of fibrosis following ischemia/reperfusion injury. Jang HS; Han SJ; Kim JI; Lee S; Lipschutz JH; Park KM Biochim Biophys Acta; 2013 Dec; 1832(12):1998-2008. PubMed ID: 23851027 [TBL] [Abstract][Full Text] [Related]
9. BmpR1A is a major type 1 BMP receptor for BMP-Smad signaling during skull development. Pan H; Zhang H; Abraham P; Komatsu Y; Lyons K; Kaartinen V; Mishina Y Dev Biol; 2017 Sep; 429(1):260-270. PubMed ID: 28641928 [TBL] [Abstract][Full Text] [Related]
10. Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis. Sugimoto H; LeBleu VS; Bosukonda D; Keck P; Taduri G; Bechtel W; Okada H; Carlson W; Bey P; Rusckowski M; Tampe B; Tampe D; Kanasaki K; Zeisberg M; Kalluri R Nat Med; 2012 Feb; 18(3):396-404. PubMed ID: 22306733 [TBL] [Abstract][Full Text] [Related]
11. Promotion of cell proliferation by clusterin in the renal tissue repair phase after ischemia-reperfusion injury. Nguan CY; Guan Q; Gleave ME; Du C Am J Physiol Renal Physiol; 2014 Apr; 306(7):F724-33. PubMed ID: 24477687 [TBL] [Abstract][Full Text] [Related]
12. Wnt9a Promotes Renal Fibrosis by Accelerating Cellular Senescence in Tubular Epithelial Cells. Luo C; Zhou S; Zhou Z; Liu Y; Yang L; Liu J; Zhang Y; Li H; Liu Y; Hou FF; Zhou L J Am Soc Nephrol; 2018 Apr; 29(4):1238-1256. PubMed ID: 29440280 [TBL] [Abstract][Full Text] [Related]
13. RGMb protects against acute kidney injury by inhibiting tubular cell necroptosis via an MLKL-dependent mechanism. Liu W; Chen B; Wang Y; Meng C; Huang H; Huang XR; Qin J; Mulay SR; Anders HJ; Qiu A; Yang B; Freeman GJ; Lu HJ; Lin HY; Zheng ZH; Lan HY; Huang Y; Xia Y Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1475-E1484. PubMed ID: 29382757 [TBL] [Abstract][Full Text] [Related]
14. SCUBE1-enhanced bone morphogenetic protein signaling protects against renal ischemia-reperfusion injury. Liao WJ; Lin H; Cheng CF; Ka SM; Chen A; Yang RB Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):329-338. PubMed ID: 30414502 [TBL] [Abstract][Full Text] [Related]
15. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts. Kamiya N; Kobayashi T; Mochida Y; Yu PB; Yamauchi M; Kronenberg HM; Mishina Y J Bone Miner Res; 2010 Feb; 25(2):200-10. PubMed ID: 19874086 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC. Chen X; Zankl A; Niroomand F; Liu Z; Katus HA; Jahn L; Tiefenbacher C J Mol Cell Cardiol; 2006 Jul; 41(1):26-33. PubMed ID: 16716349 [TBL] [Abstract][Full Text] [Related]
19. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension. Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795 [TBL] [Abstract][Full Text] [Related]
20. Epithelial Bmp (Bone morphogenetic protein) signaling for bulbourethral gland development: a mouse model for congenital cystic dilation. Omori A; Harada M; Ohta S; Villacorte M; Sugimura Y; Shiraishi T; Suzuki K; Nakagata N; Ito T; Yamada G Congenit Anom (Kyoto); 2011 Sep; 51(3):102-9. PubMed ID: 21848994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]